Caporali, S., Alvino, E., Lacal, P. M., Ruffini, F., Levati, L., Bonmassar, L., . . . D’Atri, S. (2017). Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib. Oncotarget.
Chicago Style CitationCaporali, Simona, et al. "Targeting the PTTG1 Oncogene Impairs Proliferation and Invasiveness of Melanoma Cells Sensitive or With Acquired Resistance to the BRAF Inhibitor Dabrafenib." Oncotarget 2017.
Cita MLACaporali, Simona, et al. "Targeting the PTTG1 Oncogene Impairs Proliferation and Invasiveness of Melanoma Cells Sensitive or With Acquired Resistance to the BRAF Inhibitor Dabrafenib." Oncotarget 2017.
Atenció: Aquestes cites poden no estar 100% correctes.